DOKI Kosuke

Researcher's full information

Articles
  • A Survey on Trial Site Visit Activities of Clinical Research Associates: A Consideration Toward Improving the Efficiency of Clinical Trials
    飯村 美波; 土岐 浩介; 嶋田 沙織; 鶴嶋 英夫; 松村 明; 本間 真人
    Jpn. J. Clin. Pharmacol. Ther./46(2)/pp.71-75, 2015
  • Stereoselective analysis of flecainide enantiomers using reversed-phase liquid chromatography for assessing CYP2D6 activity
    Kousuke Doki; Sekiguchi Yukio; Kuga Keisuke; Aonuma Kazutaka...
    BIOMEDICAL CHROMATOGRAPHY/28(9)/pp.1193-1198, 2014-09
  • SCN5A promoter haplotype affects the therapeutic range for serum flecainide concentration in Asian patients
    Doki Kosuke
    Pharmacogenet Genomics/23(7)/pp.349-354, 2013
  • CYP2D6 genotype affects age-related decline in flecainide clearance: a population pharmacokinetic analysis
    Doki Kosuke
    Pharmacogenet Genomics/22(11)/pp.777-783, 2012
  • Open-well stability of reagent cartridge for affinity column-mediated immunoassay of blood tacrolimus concentration
    Doki Kosuke
    Clin Chim Acta/411(11-12)/pp.888-889, 2010
  • Difference in blood tacrolimus concentration between ACMIA and MEIA in samples with low haematocrit values
    Doki Kosuke
    J Pharm Pharmacol/62(9)/pp.1185-1188, 2010
  • 処方オーダーシステムと連動した麻薬管理システムの導入と評価
    土岐 浩介
    日本病院薬剤師会雑誌/45/pp.1099-1101, 2009
  • Effects of CYP2D6 genotypes on age-related change of flecainide metabolism: involvement of CYP1A2-mediated metabolism
    Doki Kosuke; Homma Masato; Kuga Keisuke; Aonuma Kazutaka...
    Br J Clin Pharmacol/68(1)/pp.89-96, 2009
  • Investigation of glucocorticoid-induced side effects in patients with autoimmune diseases
    Nakajima Aya; 土岐 浩介; Homma Masato; Sagae Terumi; Saito R...
    Yakugaku Zasshi/129(4)/pp.445-450, 2009
  • Co-administration of proton pump inhibitors delays elimination of plasma methotrexate in high-dose methotrexate therapy
    Doki Kosuke
    Br J Clin Pharmacol/67(1)/pp.44-49, 2009
  • Impact of CYP3A5 genetic polymorphism on pharmacokinetics of tacrolimus in healthy Japanese subjects
    Doki Kosuke
    Br J Clin Pharmacol/66(1)/pp.154-155, 2008
  • Gender-associated differences in pharmacokinetics and anti-arrhythmic effects of flecainide in Japanese patients with supraventricular tachyarrhythmia
    Doki Kosuke
    Eur J Clin Pharmacology./63(10)/pp.951-957, 2007
  • Impact of serum flecainide level on control of atrial fibrillation in a case treated with cardiac resynchronization therapy
    Doki Kosuke
    J Clin Pharm Ther/32(4)/pp.409-411, 2007
  • Effect of CYP2D6 genotype on flecainide pharmacokinetics in Japanese patients with supraventricular tachyarrhythmia
    Doki Kosuke
    Eur J Clin Pharmacol/62(11)/pp.919-926, 2006
  • Assessment of serum flecainide trough levels in patients with tachyarrhythmia
    Doki Kosuke
    J Pharm Pharmacol/57(1)/pp.47-51, 2005
  • Simultaneous determination of serum flecainide and its metabolites by using high performance liquid chromatography
    Doki Kosuke
    J Pharm Biomed Anal/35(5)/pp.1307-1312, 2004
  • Drug interaction of tizanidine and fluvoxamine
    Doki Kosuke
    Clin Pharmacol Ther/76(5), 2004
  • Effects of absorption rate on the pre-systemic chiral inversion of ibuprofen in rabbits
    Doki Kosuke
    J Pharm Pharmacol/55(8)/pp.1091-1097, 2003